Centroid markers for image analysis of high density clusters in complex polynucleotide sequencing

• US 9,758,825 B2
• Filed: 06/24/2014
• Issued: 09/12/2017
• Est. Priority Date: 09/15/2009
• Status: Active Grant

• Current Assignee: Illumina Cambridge Limited (Illumina Incorporated)
• Original Assignee: Illumina Cambridge Limited (Illumina Incorporated)
• Inventors: Kersey, Alan D., Boutell, Jonathan Mark
• Primary Examiner(s): THOMAS, DAVID C
• Application Number:
  US14/313,671
• Publication Number:
  US 20140309143A1
• Time in Patent Office: 1,176 Days
• Field of Search: None
• CPC Class Codes: C12Q 1/6806 Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay C12Q1/6804 takes precedence
• CPC Class Codes: C12Q 1/6874 involving nucleic acid arrays, e.g. sequencing by hybridisation
• CPC Class Codes: C12Q 2535/122 Massive parallel sequencing
• CPC Class Codes: C12Q 2563/107 fluorescence
• CPC Class Codes: C12Q 2565/543 characterised by the use of two or more capture oligonucleotide primers in concert, e.g. bridge amplification

Abstract

Improved compositions, methods, apparatus, and kits for high-throughput nucleic acid amplification, detection and sequencing are disclosed. A nucleic acid cluster having an identifiable center is produced by generating on a solid support an immobilized nucleic acid complement from a template, one of which comprises a detectable label; and amplifying the complement and the template to obtain a nucleic acid cluster on the support, the cluster having a substantially central location marked by the detectable label and a surrounding region comprising immobilized copies. Also disclosed are nucleotide sequence determination in nucleic acid clusters so produced, center position annotation in the clusters, assignment of sequence information to overlapping clusters, and related compositions and methods.

Claims

1. A solid support comprising a plurality of fiducial markings, the markings comprising a ring of fluorescently labeled nucleic acids surrounding a center region lacking fluorescently labeled nucleic acids.

2. The solid support of claim 1, wherein the solid support is contained in a flow cell.

3. The solid support of claim 1, wherein the fiducial markings comprise a circular shape.

4. The solid support of claim 1, wherein the fiducial markings comprise a shape other than a circular shape.

5. The solid support of claim 1, wherein the solid support is formed by a process comprising:

(a) generating, on a solid support, at least one immobilized nucleic acid complement of at least one nucleic acid template;

(b) carrying out a first set of amplification cycles to amplify the at least one nucleic acid template and the at least one nucleic acid complement in the presence of a nucleoside analog to obtain a region comprising immobilized copies of the at least one nucleic acid template and of the at least one nucleic acid complement, the immobilized copies comprising the nucleoside analog;

(c) carrying out a second set of amplification cycles in the absence of the nucleoside analog to obtain on the solid support at least one nucleic acid cluster, wherein each cluster comprises (i) a substantially central location comprising the at least one nucleic acid template and the at least one nucleic acid complement comprising the nucleoside analog, and (ii) a surrounding region comprising one or more immobilized copies of the at least one nucleic acid template and of the at least one nucleic acid complement lacking the nucleoside analog; and

(d) selectively removing nucleic acids in the substantially central location while leaving the nucleic acids in the surrounding region, thereby producing at least one nucleic acid cluster having an identifiable center.

6. The solid support of claim 5, wherein said process further comprises:

(e) labeling the surrounding region with a detectable label.

7. The solid support of claim 6, wherein the labelling comprises binding an intercalator stain to the nucleic acids in the surrounding region.

8. The solid support of claim 6, wherein labeling comprises hybridizing a sequencing primer to the immobilized copies of the at least one nucleic acid template or of the at least one nucleic acid complement and extending the primer with at least one fluorescently labeled nucleotide.

9. The solid support of claim 6, wherein said process further comprises:

(f) detecting the detectable label in the surrounding region.